Bedoradrine

• CAT Number: I048009
• CAS Number: 194785-19-8
• Molecular Formula: C24H32N2O5
• Molecular Weight: 428.5
• Purity: 98%
• Synonyms: Bedoradrine [INN]; UNII-4EAR229231; 4EAR229231
• Target: FGFR
• Target Protein: OANCEOSLKSTLTA-REWPJTCUSA-N
• Appearance: Solid
• IUPAC Name: 2-[[(7S)-7-[[(2R)-2-hydroxy-2-[4-hydroxy-3-(2-hydroxyethyl)phenyl]ethyl]amino]-5,6,7,8-tetrahydronaphthalen-2-yl]oxy]-N,N-dimethylacetamide
• InChI: InChI=1S/C24H32N2O5/c1-26(2)24(30)15-31-21-7-4-16-3-6-20(12-19(16)13-21)25-14-23(29)17-5-8-22(28)18(11-17)9-10-27/h4-5,7-8,11,13,20,23,25,27-29H,3,6,9-10,12,14-15H2,1-2H3/t20-,23-/m0/s1
• SMILES: CN(C)C(=O)COC1=CC2=C(CCC(C2)NCC(C3=CC(=C(C=C3)O)CCO)O)C=C1

Bedoradrine (CAS 194785-19-8) is a pharmaceutical compound that acts as a selective β3-adrenergic receptor agonist. As a member of the adrenergic receptor family, activation of the β3-adrenergic receptor is associated with various physiological effects, including increased lipolysis and thermogenesis. Bedoradrine’s specificity for the β3 subtype makes it a potential candidate for conditions related to metabolic regulation, such as obesity. Research is ongoing to explore its pharmacological properties and therapeutic applications, particularly in the context of metabolic disorders where modulation of the β3-adrenergic receptor may offer benefits.